Company Information

CIN
Status
Date of Incorporation
21 October 2005
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
23 August 2023
Paid Up Capital
1,619,823,930
Authorised Capital
2,000,000,000

Directors

Mehul Dipak Dalal
Mehul Dipak Dalal
Director/Designated Partner
almost 2 years ago
Hemant Kumar Manilal Mamania
Hemant Kumar Manilal Mamania
Director/Designated Partner
over 2 years ago
Michiel Hans Leonard Wisbrun
Michiel Hans Leonard Wisbrun
Director/Designated Partner
over 2 years ago
Nishank Bhargava
Nishank Bhargava
Director/Designated Partner
almost 4 years ago
Deepak Kushalnath Shukla
Deepak Kushalnath Shukla
Director
about 5 years ago

Past Directors

Liron Weiss Bazak
Liron Weiss Bazak
Additional Director
over 4 years ago
Amol Vasant Kamath
Amol Vasant Kamath
Additional Director
almost 5 years ago
Gaurav Mathur
Gaurav Mathur
Director
about 8 years ago
Pramod Ramchandra Ghorpade
Pramod Ramchandra Ghorpade
Director
about 8 years ago
Wayne Robert Swanton
Wayne Robert Swanton
Director
over 10 years ago
Hassan Chandrasekara Krishnaprasad
Hassan Chandrasekara Krishnaprasad
Additional Director
about 12 years ago
Chinnadharavaram Sundaresan Muralidharan
Chinnadharavaram Sundaresan Muralidharan
Managing Director
almost 13 years ago
Biju Philip Abraham
Biju Philip Abraham
Director
over 14 years ago
Robert Stewart
Robert Stewart
Director
over 14 years ago
Jayant Bapna
Jayant Bapna
Director
over 14 years ago
Gary Holloway
Gary Holloway
Director
over 15 years ago
Patrick Gerard Brunner
Patrick Gerard Brunner
Director
over 15 years ago
Dhaval Kishore Vussonji
Dhaval Kishore Vussonji
Director
about 19 years ago
David Adam Buchen
David Adam Buchen
Director
about 20 years ago

Patents

An Improved Process For Preparing Darifenacin Hydrobromide

Disclosed herein is a process for the preparation of Darifenacin hydrobromide using novel intermediate of formula X, which is prepared by the reaction of compound of formula VIII with p-Toluene sulfonyl chloride in the presence of a phase transfer catalyst and alkali metal salts to give a compound of formula IX and ...

An Improved Process For Preparation Of Mirtazapine And Its Intermediate

Disclosed herein is a process for the manufacture of Mirtazapine which comprises a) hydrolysis of 1 -(3-cyanopyridyl-2)-4-methyl-2-phenylpiperazine in alkaline conditions under reflux to give l-(3-carboxypyridyl-2)-4-methyl-2-phenylpiperazine; b) reduction of l-(3-carboxypyridyl-2)-4-methyl-2-phenylpiperazine using ...

Charges

25 Crore
23 June 2009
Hdfc Bank Limited
25 Crore
23 August 2005
Standard Chartered Bank
80 Lak
29 November 2005
Standard Chartered Bank
80 Lak
18 January 2002
Corporation Bank
3 Crore
30 October 2002
Bank Of Baroda
3 Crore
30 October 2002
Bank Of Baroda
0
18 January 2002
Corporation Bank
0
29 November 2005
Standard Chartered Bank
0
23 August 2005
Standard Chartered Bank
0
23 June 2009
Hdfc Bank Limited
0
30 October 2002
Bank Of Baroda
0
18 January 2002
Corporation Bank
0
29 November 2005
Standard Chartered Bank
0
23 August 2005
Standard Chartered Bank
0
23 June 2009
Hdfc Bank Limited
0
30 October 2002
Bank Of Baroda
0
18 January 2002
Corporation Bank
0
29 November 2005
Standard Chartered Bank
0
23 August 2005
Standard Chartered Bank
0
23 June 2009
Hdfc Bank Limited
0

Documents

Form AOC-4(XBRL)-16122020-signed
List of share holders, debenture holders;-21112020
Copy of MGT-8-21112020
Form MGT-7-21112020_signed
Form MSME FORM I-30102020_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-28102020
Form DPT-3-20102020-signed
Form DIR-12-20102020_signed
Optional Attachment-(1)-19102020
Form DPT-3-01092020-signed
Form MSME FORM I-19052020_signed
Form MGT-14-09032020_signed
Altered articles of association-09032020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-09032020
Copy of MGT-8-26122019
List of share holders, debenture holders;-26122019
Form MGT-7-26122019_signed
Form DIR-12-25122019_signed
Evidence of cessation;-24122019
Notice of resignation;-24122019
Optional Attachment-(2)-24122019
Declaration of the appointee director, Managing director, in Form No. DIR-2;-24122019
Optional Attachment-(3)-24122019
Optional Attachment-(1)-24122019
Form MSME FORM I-08112019_signed
Form AOC-4(XBRL)-31102019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-25102019
Form DPT-3-29062019
Form ADT-1-22062019_signed
Copy of written consent given by auditor-14062019